☞ On deadline? For media inquiries CLICK HERE.
USA Today turns to APC to answer the question ‘What are patients going to do now?’
In an article aimed at healthcare execs, the question of the impending demand lingers
The Reuters story — and APC’s perspective — was picked up by a lot of news outlets.
When attorneys general are being … let’s call it “misled” into conflating unlicensed pharmacies with legitimate compounders.
Eli Lilly has weighed in, and APC rebuts the company’s contentions
NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss drugs.
FOLLOW US
